CHEMBONDCH CHEMBONDCH NSE
Company Profile ↓Company Overview
CHEMBONDCH (CHEMBONDCH) is a publicly traded company listed on NSE with a market capitalization of ₹712.76 Cr. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 16.9%, reflecting efficient use of shareholder capital.
Return on capital employed stands at 19.9%.
Net profit has compounded at 11.7% per year over the last five years.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Mar 2026 Revenue of ₹326.15 Cr (+11.6% YoY); net profit ₹34.96 Cr.
- Trailing 12 Months Year-on-year growth — revenue +11.6%, earnings +12.6%.
- 5-Year Trend Long-term compounding — revenue CAGR -9.4%, profit CAGR 11.7%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -9.44% |
| 1 Year: | 11.59% |
Compounded Profit Growth
| 5 Years: | 11.69% |
| 1 Year: | 12.62% |
Stock Price Performance
| 1 Year: | +49.52% |
| 6 Months: | +76.76% |
| 3 Months: | +72.23% |
| 1 Month: | +54.48% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)74.39 · Overbought
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Profit CAGR of 11.7% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Revenue declined at -9.4% CAGR over 5 years.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in INR.
| Metric | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 64.00 Cr | 75.00 Cr | 74.88 Cr | 78.01 Cr | 65.38 Cr | 73.00 Cr | 86.35 Cr | 101.38 Cr |
| Cost of Revenue | - | - | 35.36 Cr | 37.55 Cr | 30.38 Cr | - | 44.82 Cr | 51.77 Cr |
| Gross Profit | - | - | 39.52 Cr | 40.46 Cr | 35.00 Cr | - | 41.52 Cr | 49.62 Cr |
| Operating Expenses | 57.00 Cr | 67.00 Cr | 26.05 Cr | 30.64 Cr | 27.77 Cr | 62.00 Cr | 30.48 Cr | 35.27 Cr |
| Operating Income | 6.00 Cr | 7.00 Cr | 13.47 Cr | 9.82 Cr | 7.23 Cr | 10.00 Cr | 11.04 Cr | 14.35 Cr |
| EBITDA | 7.00 Cr | 8.00 Cr | 14.59 Cr | 14.18 Cr | 11.14 Cr | 11.00 Cr | 13.40 Cr | 15.69 Cr |
| Interest Expense | 0 | 0 | 23.53 L | 11.35 L | 15.08 L | 0 | 17.17 L | 20.96 L |
| Pretax Income | 8.00 Cr | 9.00 Cr | 13.41 Cr | 11.62 Cr | 9.80 Cr | 10.00 Cr | 11.92 Cr | 13.95 Cr |
| Tax Provision | 2.48 Cr | 2.16 Cr | 3.44 Cr | 2.92 Cr | 3.53 Cr | 2.50 Cr | 2.21 Cr | 2.32 Cr |
| Net Income | 6.00 Cr | 7.00 Cr | 9.97 Cr | 8.81 Cr | 6.26 Cr | 7.00 Cr | 9.74 Cr | 11.73 Cr |
| Diluted EPS | - | - | 3.71 | 3.27 | 2.33 | 2.70 | 3.62 | 4.36 |
Profit & Loss (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | - | 439.13 Cr | 282.22 Cr | 292.27 Cr | 326.15 Cr |
| Cost of Revenue | - | 279.11 Cr | 152.20 Cr | 143.45 Cr | 161.82 Cr |
| Gross Profit | - | 160.01 Cr | 130.02 Cr | 148.83 Cr | 164.33 Cr |
| Operating Expenses | - | 127.44 Cr | 89.66 Cr | 111.82 Cr | 122.35 Cr |
| Operating Income | - | 32.57 Cr | 40.36 Cr | 37.01 Cr | 41.98 Cr |
| EBITDA | - | 38.97 Cr | 45.15 Cr | 47.77 Cr | 51.30 Cr |
| Interest Expense | - | 52.74 L | 8.78 L | 66.76 L | 68.28 L |
| Pretax Income | - | 33.94 Cr | 42.45 Cr | 42.17 Cr | 45.26 Cr |
| Tax Provision | - | 8.77 Cr | 12.43 Cr | 11.26 Cr | 10.48 Cr |
| Net Income | - | 25.10 Cr | 30.11 Cr | 31.04 Cr | 34.96 Cr |
| Diluted EPS | 5.18 | 9.33 | 11.20 | - | 13.00 |
Balance Sheet (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Total Assets | - | 401.94 Cr | 183.03 Cr | 216.12 Cr | 253.67 Cr |
| Current Assets | - | 219.34 Cr | 151.84 Cr | 182.86 Cr | 216.48 Cr |
| Cash & Equivalents | - | 9.23 Cr | 6.51 Cr | 7.10 Cr | 12.10 Cr |
| Inventory | - | 34.20 Cr | 17.34 Cr | 18.26 Cr | 23.45 Cr |
| Receivables | - | 115.19 Cr | 77.19 Cr | 100.36 Cr | 114.36 Cr |
| Total Liabilities | - | 78.86 Cr | 38.79 Cr | 41.30 Cr | 46.25 Cr |
| Current Liabilities | - | 76.86 Cr | 35.13 Cr | 38.04 Cr | 42.42 Cr |
| Long Term Debt | 70.61 L | 78.93 L | - | - | - |
| Total Debt | 1.51 Cr | 6.53 Cr | 6.68 Cr | - | - |
| Total Equity | - | 321.69 Cr | 143.50 Cr | 174.21 Cr | 206.99 Cr |
| Shares Outstanding | - | 2.69 Cr | 2.69 Cr | 2.69 Cr | 2.69 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 94.98 L | -55.62 Cr | 9.79 Cr | 8.29 Cr |
| Investing Cash Flow | - | 1.36 Cr | 48.39 Cr | -8.52 Cr | 75.52 L |
| Financing Cash Flow | - | -2.06 Cr | 12.85 Cr | -66.76 L | -4.04 Cr |
| Capital Expenditure | - | -14.64 Cr | -19.82 Cr | -4.58 Cr | -6.91 Cr |
| Free Cash Flow | - | -13.69 Cr | -75.44 Cr | 5.21 Cr | 1.38 Cr |
| Net Change in Cash | - | 24.89 L | 5.62 Cr | 59.50 L | 5.00 Cr |
Ratios (Annual)
Figures in %.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Margin % | - | 36.4% | 46.1% | 50.9% | 50.4% |
| Operating Margin % | - | 7.4% | 14.3% | 12.7% | 12.9% |
| Net Margin % | - | 5.7% | 10.7% | 10.6% | 10.7% |
| ROE % | - | 7.8% | 21.0% | 17.8% | 16.9% |
| ROCE % | - | 10.0% | 27.3% | 20.8% | 19.9% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CHEMBONDCH
Chembond Chemicals Lists at ₹170; Surges 90% on Debut - HDFC Sky
<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxQd3hwVHRLak5KeHRPNnd2VmVnSjVWekFkY1p4Y1lNVzh6QmNYbmVSWGgtTDlSY1RVeXc5N2hWOS1vak5ZeTBmYzZSM3lUN3Jxdk90V09Gb3ZlUTBITjRwa24xbDE3bTl6VHBDMmpxQlN5UTIwczVHa1I5SW5GVVRSRlRjWlBmNE1KbDRXN1…
RPEL Stock Price and Chart — NSE:RPEL - TradingView
<a href="https://news.google.com/rss/articles/CBMiWEFVX3lxTE1weHMyRzg0SVQ4cWhPY0tkUkR1ZmE5UktjNE9xVUs2c2Q1dVJvU2k5M1JGTU5MVEtoSU50Szk5REdQVi04RThySk50dkduNUJwMGVUd09NLU4?oc=5" target="_blank">RPEL Stock Price and Chart — NSE:RPEL</a> &…
DDEVPLSTIK Stock Price and Chart — NSE:DDEVPLSTIK - TradingView
<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE45bXRoNkhmM2x3cW13d2lWQ0t2cjFFOGZGY3hQY0NMNm01WDVzNUxJb0xNbzZsZE5qUE50WHFSdGg5ZmJrWW4yNlc5MmxUamxDT3dKWHh1cFVmS2QwLVdyNA?oc=5" target="_blank">DDEVPLSTIK Stock Price and Chart — NS…
FOSECOIND Stock Price and Chart — NSE:FOSECOIND - TradingView
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1VQXQ5REJvcVJYQUctZ2EzZ3hEVTV2RWpYYVktYkJFU19wZXJTbGMySFVLS2F1VU9lUUN4QlZTNUJfT1piUUhrdEREX0NLQzlSNVg2dDdqeF8xWE9IeWVr?oc=5" target="_blank">FOSECOIND Stock Price and Chart — NSE:F…
CHEMBONDCH — Frequently Asked Questions
What is the current share price of CHEMBONDCH?
As of 2026-07-15 09:52 IST, CHEMBONDCH trades at ₹265.00 on NSE. Its 52-week range is ₹106.24 to ₹265.00.
What is the market capitalisation of CHEMBONDCH?
CHEMBONDCH has a market capitalisation of ₹712.76 Cr on NSE.
What is the P/E ratio of CHEMBONDCH?
CHEMBONDCH trades at a trailing price-to-earnings (P/E) ratio of 20.38. Its price-to-book (P/B) ratio is 3.32.
What is the return on equity (ROE) of CHEMBONDCH?
CHEMBONDCH has a return on equity (ROE) of 16.89%. Its return on capital employed (ROCE) is 19.87%.
Is CHEMBONDCH a good stock to buy?
This page provides a data-driven analysis of CHEMBONDCH, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.